Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study

Treating beyond endoscopic remission, aiming for histological remission, is an emerging target in ulcerative colitis (UC). Patient reported outcome measurements (PROMs) become increasingly important, but its association with histology is unclear.